| Peritoneal and Retroperitoneal Neoplasm studied in …STUDIED_INderived200 of 887show all (up to 200) |
|---|
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06351475NA · recruiting Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06487481Phase 1 · recruiting Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504588Phase 2 · recruiting Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715903Phase 1 · not yet recruiting Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005927completed Study of Adrenal Gland Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05257408Phase 3 · active not recruiting Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06057935Phase 2 · recruiting A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776691Phase 3 · recruiting A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708753Phase 3 · recruiting A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004847Phase 1 · recruiting Diagnosis of Pheochromocytoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005654recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001880Phase 2 · recruiting Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05446298Phase 2 · active not recruiting ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213804Phase 3 · recruiting A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07495124Phase 2 · recruiting IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00515372Phase 1 · active not recruiting Depression Treatment and Screening in Ovarian Cancer Patients · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06900595Phase 2 · recruiting Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743138Phase 2 · not yet recruiting STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06025747Phase 1 · recruiting A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03374215recruiting Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080946early Phase 1 · suspended Using Aspirin to Improve Immunological Features of Ovarian Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915025Phase 3 · recruiting Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012817Phase 1/Phase 2 · active not recruiting Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575935Phase 3 · recruiting Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772869NA · recruiting Uterine Lavage to Detect Ovarian Cancer Risk · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743164Phase 3 · not yet recruiting A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04031677Phase 3 · recruiting Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04394858Phase 2 · active not recruiting Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812779not yet recruiting Thyroid Health Outcomes Registry for Surgery · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595892Phase 2 · active not recruiting Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01617382recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05617755Phase 1 · active not recruiting AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286814Phase 2 · recruiting PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06279442completed Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort · condition mapped PROBABILISTIC · 887 trials mapped (257 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086567completed Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02839707Phase 2/Phase 3 · active not recruiting Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492070Phase 2 · recruiting Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034927Phase 2 · active not recruiting Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Sensitive Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02402244recruiting Project: Every Child for Younger Patients With Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206060Phase 2 · recruiting Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847063Phase 1 · recruiting Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07785557NA · not yet recruiting Remimazolam Versus Propofol for Early Recovery After Cytoreductive Surgery · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453674recruiting German Adrenocortical Carcinoma Registry · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02068794Phase 1/Phase 2 · active not recruiting MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03355976Phase 2 · active not recruiting BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04673448Phase 1 · active not recruiting Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604315Phase 1 · recruiting Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03740165Phase 3 · completed Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427798Phase 1/Phase 2 · recruiting Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415709early Phase 1 · active not recruiting Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05231122Phase 2 · recruiting Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05844865NA · recruiting Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis · condition mapped PROBABILISTIC · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06377033NA · recruiting Using the EHR to Advance Genomic Medicine Across a Diverse Health System · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02217956Phase 1 · completed Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03943173early Phase 1 · active not recruiting Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00488878recruiting Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05114421Phase 2 · active not recruiting Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06580314Phase 3 · recruiting Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015844available A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03026062Phase 2 · completed Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910657Phase 1 · recruiting IDOV-Immune for Advanced Solid Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07653594NA · not yet recruiting TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101788Phase 2/Phase 3 · completed Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554328Phase 2 · active not recruiting Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579366Phase 1/Phase 2 · recruiting Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01659203Phase 1/Phase 2 · recruiting Proton or Photon RT for Retroperitoneal Sarcomas · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535312Phase 1/Phase 2 · active not recruiting Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627443Phase 1 · active not recruiting Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616534Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05460000Phase 2 · recruiting A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333616Phase 2 · active not recruiting Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586661Phase 1 · completed Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943612recruiting Colorectal Resections in Patients With Retroperitoneal Sarcoma · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022213Phase 2 · active not recruiting A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714551Phase 2 · not yet recruiting Zanzalintinib in Unresectable and Progressive MPGGs · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02721732Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469764Phase 2 · recruiting Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07538791not yet recruiting Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113487Phase 2 · active not recruiting P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03579316Phase 2 · active not recruiting Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092373Phase 1 · recruiting Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05465941Phase 2 · active not recruiting PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06906341Phase 2 · recruiting Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07377747recruiting Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116648Phase 1/Phase 2 · active not recruiting Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Primary Peritoneal Serous Papillary Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05887609Phase 2 · recruiting An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650986Phase 1/Phase 2 · active not recruiting Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587311Phase 2 · active not recruiting Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04573816completed Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06327477Phase 1/Phase 2 · recruiting Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Malignant Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680205Phase 2 · recruiting An Experimental Study of Belzutifan Impact on Catecholamine Metabolism · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05429970NA · recruiting A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674615Phase 1 · not yet recruiting IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04387227Phase 2 · completed Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05185947Phase 2 · completed Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05071937Phase 2 · recruiting ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538091Phase 2 · recruiting Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050268recruiting Familial Investigations of Childhood Cancer Predisposition · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541720early Phase 1 · active not recruiting 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04055649Phase 2 · recruiting ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041516Phase 1 · recruiting A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07330271NA · recruiting PTC-Guided Therapy for Peritoneal Mesothelioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06756035Phase 1 · recruiting CT-95 in Advanced Cancers Associated With Mesothelin Expression · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04027868completed Genomic BRCA and Extensive ovArian Cancer Testing · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607692Phase 1/Phase 2 · recruiting Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00951496Phase 3 · completed Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05445778Phase 3 · active not recruiting Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730347Phase 2 · recruiting A Study of Lorigerlimab in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07617753Phase 1/Phase 2 · recruiting Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107289Phase 2 · recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01167712Phase 3 · active not recruiting Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00700414recruiting International Pediatric Adrenocortical Tumor Registry · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189403Phase 1 · recruiting A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer · condition mapped PROBABILISTIC · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03430700Phase 2 · completed Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04701645Phase 1 · recruiting Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636618Phase 1/Phase 2 · recruiting Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913674Phase 2 · recruiting Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) · condition mapped PROBABILISTIC · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04295577completed Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04314401active not recruiting National Cancer Institute "Cancer Moonshot Biobank" · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691504Phase 1 · active not recruiting Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399371Phase 2 · completed Pembrolizumab in Treating Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00457587active not recruiting Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00568139active not recruiting Evaluation of Side Effects of Mitotane · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669266recruiting Adrenal Tumors - Pathogenesis and Therapy · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03127774Phase 2 · active not recruiting Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05271318Phase 1/Phase 2 · active not recruiting Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756754NA · completed Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05337735Phase 2 · suspended A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06295965recruiting Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02659241early Phase 1 · active not recruiting Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066333Phase 2 · recruiting Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04189783Phase 2 · active not recruiting Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial) · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01163383available 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06274541completed Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06753136NA · recruiting Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361436Phase 1 · active not recruiting Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Malignant Retroperitoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04516447Phase 1 · recruiting A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516275not yet recruiting Prospective Cohort Study of Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02673333Phase 2 · active not recruiting Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017131Phase 1 · active not recruiting Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05335993Phase 2 · active not recruiting A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02873962Phase 2 · active not recruiting A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04498117Phase 3 · active not recruiting Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290193Phase 2 · recruiting Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06969833NA · recruiting Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02758951Phase 2/Phase 3 · active not recruiting Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04095364Phase 3 · active not recruiting Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919629Phase 2 · recruiting APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198804Phase 1/Phase 2 · completed A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07480954Phase 1/Phase 2 · recruiting Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726330NA · not yet recruiting Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06144853completed The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study. · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06483048Phase 1 · recruiting MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04358107active not recruiting Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03968406Phase 1 · recruiting Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06184867NA · completed Choices About Genetic Testing And Learning Your Risk With Smart Technology · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01970722Phase 1 · active not recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04785287Phase 1/Phase 2 · terminated Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Malignant Adrenal Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03839498Phase 2 · active not recruiting Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03946527Phase 2 · active not recruiting LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636540early Phase 1 · recruiting In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432932recruiting Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Malignant Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05527184Phase 1 · active not recruiting First in Human Study of IMGN151 in Recurrent Gynaecological Cancers · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03165721Phase 2 · terminated A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006013Phase 2 · recruiting Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer · condition mapped CURATED_BROADER · 887 trials mapped (257 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06929013NA · recruiting Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer. · condition mapped PROBABILISTIC · 887 trials mapped (257 active) | — | — | Peritoneal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04711135Phase 2 · active not recruiting Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07396116NA · not yet recruiting Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02) · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Retroperitoneal Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04781088Phase 2 · active not recruiting Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active) | — | — | Platinum-Resistant Primary Peritoneal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875144Phase 2 · suspended Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01022515NA · completed Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma · condition mapped ALIAS · 887 trials mapped (257 active) | — | — | Adrenal Gland Pheochromocytoma | 1 | Observed | clinicaltrials | graph → |